USPTO serial 99940305
DARK HORSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with DARK HORSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicholas P. Coleman
Nicholas P. Coleman Dickinson Wright PLLC300 West Vine Street, Suite 1700Lexington, KY 40507United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Consulting services in the field of medical product approval for commercial purposes; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; supply chain management services; business consultation services in the fields of supply chain analysis, regulation compliance and counterfeit detection; regulatory submission management, namely, assisting others in preparing and filing applications for pre-clinical, clinical, and commercial stage regulatory applications with governmental regulatory bodies; market research and business analyses; business project management services; business risk management; business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; new product commercialization services; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; business consulting services; business strategy development services; market research consultation; business consultancy; freight logistics management; business management of logistics for others; market research services; business management services, namely, supply chain logistics, reverse logistics and liquidation of goods of others; preparation of market analysis reports; project management for others for business purposes; project management for others for business purposes in the field of biopharmaceutical product development; providing business intelligence services; business strategic planning services; vendor management services for biopharmaceutical manufacturing suppliers and contract organizations; acquisition and merger consultation; business acquisitions consultation; business acquisition and merger consultation; advisory services for preparing and carrying out commercial transactions; preparation of business reports; conducting business feasibility studies | ACTIVE | — |
| 041 | Education services, namely, providing live and on-line seminars in the field of biopharmaceutical regulatory affairs; providing live and online training in the field of GMP and GxP compliance for biopharma featuring interactive chat sessions; providing education courses in the field of biopharmaceutical manufacturing and CMC offered through online, non-downloadable videos and instructor assistance; educational services, namely, conducting workshops in the field of regulatory submission writing for IND and BLA and distribution of training material in connection therewith | ACTIVE | — |
| 042 | Consulting services in the field of pharmaceutical research and development; consulting services in the field of biotechnology; consulting services in the field of genetic science; product development consultation; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; consulting services in the field of design and development of engineering processes; layout design services for clean room environments; consulting services for others in the field of design, planning, and implementation project management of scientific research, clinical trials, and commercial launch; planning and layout design services for facilities, laboratories, and cleanroom environments; providing quality assurance services in the field of GMP and GxP compliance for biopharmaceutical manufacturing; technical writing in the field of pre-clinical, clinical, and commercial stage regulatory submissions globally; technical writing in the field of drafting scientific reports, medical reports, and grants for others; consulting services in the field of pharmacogenetics; design of production facilities; design of factory buildings; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of biopharmaceutical manufacturing and clinical development | ACTIVE | — |
| 045 | Regulatory compliance consulting in the field of biotechnology; regulatory compliance consulting in the field of pharmaceuticals; consulting services concerning legal matters in the medical field; regulatory compliance consulting in the field of GMP and GxP for biopharmaceutical development and manufacturing; legal consulting services in the field of listing and tracking of foreign and domestic government regulatory requirements, for obtaining permits and regulatory compliance; regulatory compliance auditing; consultancy relating to legal compliance auditing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 14, 2026 | NWAP | NEW APPLICATION ENTERED | — |